Olivier Mailhot
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (7)
Year:
2026
Year:
2025
Accurate prediction of ligand-bound protein complexes and ranking them by affinity are central problems in drug discovery. While deep learning co-folding methods can help address these challenges, their evaluation has been hampered by the difficulties in assessing independence from training data and insufficiently large test sets. Here we test the ability of co-folding methods to predict the structures of 557 ligands bound to the SARS-CoV-2 NSP3 macrodomain (Mac1) that were determined after the training cut-off dates. AlphaFold3 (AF3), Boltz-2, and Chai-1 each reproduced >50% of the Mac1 ligand poses to better than 2 Å RMSD of experiment. Despite the potential for co-folding to describe protein conformational changes that stabilize ligand binding, we did not find that common conformational rearrangements, including peptide flip and a large loop opening, were recapitulated by the co-folding prediction. For AF3 and Chai-1, ligand pose prediction confidence weakly, but significantly, tracked experimental potency, while DOCK3.7 energies were only weakly correlated. Boltz-2 affinity predictions showed the strongest correlation with measured potency and, after calibration, achieved lower mean absolute error than a baseline predictor. We next assessed whether co-folding scores could rescore docking hit-lists to distinguish true ligands from non-binders among hundreds of molecules prospectively experimentally tested against AmpC β-lactamase, the dopamine D4 and the σ 2 receptors. AF3 ligand pose confidence values did not separate true ligands from high-scoring false-positives as effectively as docking scores or Boltz-2 affinity predictions did. Taken together, the modest, but independent correlations of docking score and co-folding confidence or affinity suggests that integrating physics-based and deep-learning and approaches may help with hit prioritization and subsequent optimization in structure-based ligand discovery.
Year:
2025
NRGRank is a coarse-grained structurally-informed virtual screening Python package with accuracy comparable to docking-based methodologies but up to 100-fold speed increase. NRGRank is based on a coarse-grained evaluation of pairwise atom-type pseudo-energy interactions that implicitly accounts for compound and side-chain flexibility as well as limited backbone movements. We compare NRGRank to docking-based virtual screening software Glide, Autodock Vina and DOCK 3.7 on the DUD-E virtual screening benchmark using enrichment factors at 1% (EF1). We observe broad variations of EF1 values across targets, structural models and methods. For apo form or AlphaFold2 models, out of a subset of 37 targets from DUD-E, NRGRank has better EF1 values than Glide for 12 and 13 targets respectively. Even in holo form, where the accuracy of classical docking software increases, NRGRank has better EF1 values than 13, 10 and 5 targets out of 37 compared to AutoDock Vina, DOCK 3.7 and Glide respectively. Comparing the rank of true binders in Glide and NRGRank shows that true binders ranked in the top 1% are complementary between methods irrespective of the target form (AlphaFold, apo or holo). That is, utilizing NRGRank detects binders that are missed by Glide (and presumably other methods), whereas those found by Glide are missed by NRGRank. Furthermore, we observe that most hits found by NRGRank within the top 50 predictions (4.38 ± 5.49 hits on average for AF2 targets) remain once the top 1% of predictions are re-scored with Glide, but the hit rate within the top 50 predictions increases. NRGRank can evaluate one molecule in 0.3 s on average, enabling a modern laptop with 8 cores to screen 1,000,000 molecules in 24 hours – up to two orders of magnitude faster than the reported speed of DOCK 3.7, AutoDock Vina running on GPUs and Glide. NRGRank occupies a unique niche among tools for virtual screening being insensitive to structural inaccuracies but with comparable accuracy as state-of-the-art docking methods and fast as AI-based methods but without the dangers of overfitting as it is based on 780 pseudo-energy parameters. Combined with the fact that NRGRank does not require extensive or expensive computational resources or expert pre-processing of targets, it is unique in making high-performance ultra-massive virtual screening accessible to all.
Year:
2025
Year:
2024
The µ -opioid receptor (MOR) is a G-protein coupled receptor involved in nociception and is the primary target of opioid drugs. Understanding the relationships between ligand structure, receptor dynamics, and efficacy in activating MOR is crucial for drug discovery and development. Here, we use coarse-grained normal mode analysis to predict ligand-induced changes in receptor dynamics with the Quantitative Dynamics Activity Relationships (QDAR) DynaSig-ML methodology, training a LASSO regression model on the entropic signatures (ES) computed from ligand-receptor complexes. We train and validate the methodology using a dataset of 179 MOR ligands with experimentally measured efficacies split into strickly chemically different cross-validation sets. By analyzing the coefficients of the ES LASSO model, we identified key residues involved in MOR activation, several of which have mutational data supporting their role in MOR activation. Additionally, we explored a contacts-only LASSO model based on ligand-protein interactions. While the model showed predictive power, it failed at predicting efficacy for ligands with low structural similarity to the training set, emphasizing the importance of receptor dynamics for predicting ligand-induced receptor activation. Moreover, the low computational cost of our approach, at 3 CPU seconds per ligand-receptor complex, opens the door to its application in large-scale virtual screening contexts. Our work contributes to a better understanding of dynamics-function relationships in the µ -opioid receptor and provides a framework for predicting ligand efficacy based on ligand-induced changes in receptor dynamics. Contact [email protected]
Year:
2024
Year:
2023
Collaborators (11)
R. Jeffrey Neitz
Professor
University of California, San Francisco
Brian K. Shoichet
University of California, San Francisco
Nevan Krogan
Professor
University of California, San Francisco
Takaya Togo
Institute of Science Tokyo
John Irwin
Adjunct Associate Professor
UCSF
Alan Ashworth
University of California, San Francisco
Fangyu Liu
Assistant Professor
University of Texas Southwestern Medical Center
Adam Renslo
Professor
University of California, San Francisco
Rafael Najmanovich
Professor
Université de Montréal
Francois Major
Full Professor
Université de Montréal
James Fraser
Professor
University of California, San Francisco
Make your next move.
Prepare your application
Review drafts before you send them.